Linda Pissott Reig, shareholder in the firm's FDA & Biotechnology practice, comments on the New Jersey Supreme Court's dismissal of hundreds of product-liability lawsuits and the potential impact on the industry in New Jersey in STAT News' "Once Again, A New Jersey Court Gives Pharma A Boost in Lawsuits Filed By Consumers."

Linda said: “Companies should demonstrate they have done what they can to communicate with FDA about information for updating labels, but many times, we don’t have certainty from the courts about what information is enough. So the companies are between a rock and a hard place. I don’t know we’ve seen a court act as decisively as this one in a long time.”